TY - STD TI - WHO: Addendum to the 2006 WHO guidelines on antiretroviral therapy for HIV infection in adults and adolescents. (date last accessed 28 September 2008)http://www.who.int/hiv/art/ARTadultsaddendum.pdf UR - http://www.who.int/hiv/art/ARTadultsaddendum.pdf ID - ref1 ER - TY - JOUR AU - Boulle, A. AU - Orrell, C. AU - Kaplan, R. AU - van Cutsem, G. AU - McNally, M. AU - Hilderbrand, K. PY - 2007 DA - 2007// TI - Substitution due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral treatment in a large South African cohort JO - Antivir Ther VL - 12 ID - Boulle2007 ER - TY - JOUR AU - De Wit, S. AU - Sabin, C. A. AU - Weber, R. AU - Worm, S. W. AU - Reiss, P. AU - Cazanave, C. PY - 2008 DA - 2008// TI - Incidence and risk factors for new onset diabetes in HIV-infected patients. The data collection on adverse events of anti-HIV drugs (D: A: D) study JO - Diabetes Care VL - 31 UR - https://doi.org/10.2337/dc07-2013 DO - 10.2337/dc07-2013 ID - De Wit2008 ER - TY - CHAP PY - 2006 DA - 2006// BT - Antiretroviral therapy for HIV infection in adults and adolescents in resource-limited settings: towards universal access PB - World Health Organization CY - Geneva ID - ref4 ER - TY - JOUR AU - Hill, A. AU - Ruxrungtham, K. AU - Hanvanich, M. AU - Katlama, C. AU - Wolf, E. AU - Soriano, V. PY - 2007 DA - 2007// TI - Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment JO - Expert Opin Pharmacother VL - 8 UR - https://doi.org/10.1517/14656566.8.5.679 DO - 10.1517/14656566.8.5.679 ID - Hill2007 ER - TY - JOUR AU - Kakuda, T. N. PY - 2000 DA - 2000// TI - Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor -induced mitochondrial toxicity JO - Clinical therapeutics VL - 22 UR - https://doi.org/10.1016/S0149-2918(00)90004-3 DO - 10.1016/S0149-2918(00)90004-3 ID - Kakuda2000 ER - TY - JOUR AU - Velsor, L. AU - Kovacevic, M. AU - Goldstein, M. AU - Leitner, H. M. AU - Lewis, W. AU - Day, B. J. PY - 2004 DA - 2004// TI - Mitochondrial oxidative stress in human hepatoma cells exposed to stavudine JO - Toxicology and Applied pharmacology VL - 199 UR - https://doi.org/10.1016/j.taap.2004.03.005 DO - 10.1016/j.taap.2004.03.005 ID - Velsor2004 ER - TY - JOUR AU - Aarnoutse, R. E. AU - Schapiro, J. M. AU - Boucher, C. A. AU - Hekster, Y. A. AU - Burger, D. M. PY - 2003 DA - 2003// TI - Therapeutic Drug Monitoring. An Aid to Optimising Response to Antiretroviral Drugs? JO - Drugs VL - 63 UR - https://doi.org/10.2165/00003495-200363080-00002 DO - 10.2165/00003495-200363080-00002 ID - Aarnoutse2003 ER - TY - JOUR AU - ter Hofstede, H. J. M. AU - Koopmans, P. P. AU - Burger, D. M. PY - 2008 DA - 2008// TI - Stavudine plasma concentrations and lipoatrophy JO - Journal of Antimicrobial Chemotherapy VL - 61 UR - https://doi.org/10.1093/jac/dkn041 DO - 10.1093/jac/dkn041 ID - ter Hofstede2008 ER - TY - JOUR PY - 2008 DA - 2008// TI - Diagnosis and classification of diabetes mellitus JO - Diabetes care VL - 31 UR - https://doi.org/10.2337/dc08-S055 DO - 10.2337/dc08-S055 ID - ref10 ER - TY - JOUR AU - Grundy, S. M. AU - Cleeman, J. I. AU - Merz, C. N. AU - Brewer, H. B. AU - Clark, L. T. AU - Hunninghake, D. B. PY - 2004 DA - 2004// TI - Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines JO - Circulation VL - 110 UR - https://doi.org/10.1161/01.CIR.0000133317.49796.0E DO - 10.1161/01.CIR.0000133317.49796.0E ID - Grundy2004 ER - TY - JOUR AU - Carr, A. AU - Law, M. PY - 2003 DA - 2003// TI - HIV lipodystrophy case definition study JO - JAIDS VL - 33 ID - Carr2003 ER - TY - STD TI - ACTG adherence follow-up questionnaire. on the 22 December 2006, http://www.caps.ucsf.edu/tools/surveys/pdf/2098.4188.pdf UR - http://www.caps.ucsf.edu/tools/surveys/pdf/2098.4188.pdf ID - ref13 ER - TY - CHAP AU - Van der Walt, J. S. AU - Cohen, K. AU - McIlleron, H. M. AU - Smith, P. J. AU - Maartens, G. AU - Karlsson, M. O. PY - 2009 DA - 2009// TI - Effect of rifampicin-based antitubercular therapy and cotrimoxazole on the population pharmacokinetics of stavudine (d4T) in HIV-1 infected patients BT - PAGE ID - Van der Walt2009 ER - TY - JOUR AU - McComsey, G. A. AU - Lo Re, V. AU - O'Riordan, M. AU - Walker, U. A. AU - Lebrecht, D. AU - Baron, E. PY - 2008 DA - 2008// TI - Effect of reducing the dose of stavudine on body composition bone density and markers of mitochondrial toxicity in HIV subjects- a randomised controlled study JO - Clin Infect Dis VL - 46 UR - https://doi.org/10.1086/529384 DO - 10.1086/529384 ID - McComsey2008 ER - TY - JOUR AU - Ait-Mohand, H. AU - Bonmarchand, M. AU - Guiguet, M. AU - Slama, L. AU - Marguet, F. AU - Behin, A. PY - 2008 DA - 2008// TI - Viral efficacy maintained and safety parameters improved with a reduced dose of stavudine JO - HIV Medicine VL - 9 UR - https://doi.org/10.1111/j.1468-1293.2008.00616.x DO - 10.1111/j.1468-1293.2008.00616.x ID - Ait-Mohand2008 ER - TY - JOUR AU - Anderson, P. L. AU - Kakuda, T. N. AU - Lichtenstein, K. A. PY - 2004 DA - 2004// TI - The cellular pharmacology of nucleoside- and nucleotide- analogue reverse-transcriptase inhibitors and its relation ship to clinical toxicities JO - Clin Infect Dis VL - 38 UR - https://doi.org/10.1086/381678 DO - 10.1086/381678 ID - Anderson2004 ER - TY - JOUR AU - Fletcher, C. V. AU - Kawle, S. P. AU - Kakuda, T. N. AU - Anderson, P. L. AU - Weller, D. AU - Bushman, L. R. PY - 2000 DA - 2000// TI - Zidovudine and lamivudine triphosphate concentration-response relationships in HIV-infected persons JO - AIDS VL - 14 UR - https://doi.org/10.1097/00002030-200009290-00010 DO - 10.1097/00002030-200009290-00010 ID - Fletcher2000 ER - TY - JOUR AU - Fletcher, C. V. AU - Anderson, P. L. AU - Kakuda, T. N. AU - Schacker, T. W. AU - Henry, C. AU - Gross, C. AU - Brundage, R. C. PY - 2002 DA - 2002// TI - Concentration-controlled compared with conventional antiretroviral therapy for HIV infection JO - AIDS VL - 16 UR - https://doi.org/10.1097/00002030-200203080-00006 DO - 10.1097/00002030-200203080-00006 ID - Fletcher2002 ER - TY - JOUR AU - Hoggard, P. G. AU - Lloyd, J. AU - Khoo, S. AU - Barry, M. G. AU - Dann, L. AU - Gibbons, S. E. PY - 2001 DA - 2001// TI - Zidovudine phosphorylation determined sequentially over 12 months in Human Immunodeficiency Virus-infected patients with or without previous exposure to antiretroviral agents JO - Antimicrobial Agents and Chemotherapy VL - 45 UR - https://doi.org/10.1128/AAC.35.3.976-980.2001 DO - 10.1128/AAC.35.3.976-980.2001 ID - Hoggard2001 ER - TY - JOUR AU - Moyle, G. AU - Boffito, M. AU - Fletcher, C. AU - Higgs, C. AU - Hay, P. E. AU - Song, I. H. PY - 2009 DA - 2009// TI - Steady state pharmacokinetics of abacavir in plasma and intracellular carbovir triphoshate following administration of abacavir at 600 mg milligrams once daily and 300 mg twice daily in Human Immunodeficiency Virus-infected subjects JO - Antimicrobial Agents and Chemotherapy VL - 53 UR - https://doi.org/10.1128/AAC.01000-08 DO - 10.1128/AAC.01000-08 ID - Moyle2009 ER - TY - CHAP AU - Domingo, P. AU - Cabeza, M. C. AU - Pruvost, A. AU - Salazar, J. AU - del Mar Guiterrez, M. AU - Mateo, M. G. PY - 2010 DA - 2010// TI - Relationship between HIV/Highly Active Antiretroviral Therapy (HAART)-Associated Lipodystrophy Syndrome and stavudine-triphosphate intracellular levels in patients with stavudine-based antiretroviral regimens BT - Clinical Infectious Diseases ID - Domingo2010 ER - TY - JOUR AU - Canter, J. A. AU - Haas, D. W. AU - Kallianpur, A. R. AU - Ritchie, M. D. AU - Robbins, G. K. AU - Shafer, W. PY - 2008 DA - 2008// TI - The mitochondrial pharmacogenomics of haplogroup T: MTND2 24*LHON4917G and antiretroviral therapy-associated peripheral neuropathy JO - The Pharmacogenomics Journal VL - 8 UR - https://doi.org/10.1038/sj.tpj.6500470 DO - 10.1038/sj.tpj.6500470 ID - Canter2008 ER - TY - CHAP AU - Canter, J. A. AU - Robbins, G. K. AU - Selph, D. AU - Clifford, D. B. AU - Kallianpur, A. R. AU - Shafer, R. PY - 2009 DA - 2009// TI - Mitochondrial Subhaplogroups and Peripheral Neuropathy during Antiretroviral Therapy (ART) among Non-Hispanic Black Participants in AIDS Clinical Trials Group (ACTG) Study 384 BT - CROI ID - Canter2009 ER - TY - JOUR AU - Hulgan, T. AU - Tebas, P. AU - Canter, J. A. AU - Mulligan, K. AU - Haas, D. W. AU - Dubé, M. AU - Grinspoon, S. PY - 2008 DA - 2008// TI - Hemochromatosis gene polymorphisms mitochondrial haplogroups and peripheral lipoatrophy during antiretroviral therapy JO - JID VL - 197 UR - https://doi.org/10.1086/528697 DO - 10.1086/528697 ID - Hulgan2008 ER - TY - JOUR AU - Hulgan, T. AU - Haubrich, R. AU - Riddler, S. AU - Tebas, P. AU - Ritchie, M. D. AU - McComsey, G. A. PY - 2009 DA - 2009// TI - Mitochondrial DNA Haplogroups and Metabolic Changes during Antiretroviral Therapy (ART) in AIDS Clinical Trials Group (ACTG) Study A5142 JO - Antiviral Therapy VL - 14 ID - Hulgan2009 ER - TY - JOUR AU - Schaad, H. AU - Petty, B. G. AU - Grasela, D. M. AU - Christofalo, B. AU - Raymond, R. AU - Stewart, M. PY - 1997 DA - 1997// TI - Pharmacokinetics and safety of a single dose of stavudine (d4T) in patients with severe hepatic impairment JO - Antimicrobial Agents and Chemotherapy VL - 41 ID - Schaad1997 ER - TY - JOUR AU - Kumar, A. K. H. AU - Ramachandran, G. AU - Rajasekaran, S. AU - Padmapriyadarsini, C. AU - Nandrenan, G. AU - Subramanyam, S. A. S. PY - 2009 DA - 2009// TI - Pharmacokinetics of lamivudine & stavudine in generic fixed- dose combinations in HIV-1 infected adults in India JO - Indian J Med Res VL - 130 ID - Kumar2009 ER - TY - STD TI - Zerit® (stavudine). http://packageinserts.bms.com/pi/pi_zerit.pdf UR - http://packageinserts.bms.com/pi/pi_zerit.pdf ID - ref29 ER - TY - JOUR AU - van Grievesen, J. AU - De Naeyer, L. AU - Mushi, T. AU - Ubarijoro, S. AU - Gashumba, D. AU - Gazille, C. AU - Zachariah, R. PY - 2007 DA - 2007// TI - High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda JO - Transactions of the Royal Society of Tropical Medicine and Hygiene VL - 101 UR - https://doi.org/10.1016/j.trstmh.2007.02.020 DO - 10.1016/j.trstmh.2007.02.020 ID - van Grievesen2007 ER - TY - JOUR PY - 2006 DA - 2006// TI - Fat distribution in women with HIV infection JO - J Acquir Immune Defic Syndr VL - 42 UR - https://doi.org/10.1097/01.qai.0000229996.75116.da DO - 10.1097/01.qai.0000229996.75116.da ID - ref31 ER - TY - JOUR AU - Podzamczer, D. AU - Ferrer, E. AU - Sanchez, P. AU - Gatell, J. M. AU - Crespo, M. AU - Fisac, C. PY - 2007 DA - 2007// TI - Less lipoatrophy and better lipid profile with abacavir as compared to stavudine. 96 week results of a randomized study JO - J Acquir Immune Def Syndrome VL - 44 UR - https://doi.org/10.1097/QAI.0b013e31802bf122 DO - 10.1097/QAI.0b013e31802bf122 ID - Podzamczer2007 ER - TY - JOUR AU - Haubrich, R. H. AU - Riddler, S. A. AU - DiRienzo, A. G. AU - Komarow, L. AU - Powderly, W. G. AU - Klingman, K. PY - 2009 DA - 2009// TI - Metabolic outcomes in a randomised trial of nucleoside nonnucleoside and protease inhibitor sparing regimens for initial HIV treatment JO - AIDS VL - 23 UR - https://doi.org/10.1097/QAD.0b013e32832b4377 DO - 10.1097/QAD.0b013e32832b4377 ID - Haubrich2009 ER - TY - JOUR AU - Carr, A. AU - Samaras, K. AU - Thorisdottir, A. AU - Kaufmann, G. R. AU - Chisholm, D. J. AU - Cooper, D. A. PY - 1999 DA - 1999// TI - Diagnosis, prediction and natural course of HIV-1 protease-inhibitor associated lipodystrophy hyperlipidaemia, and diabetes mellitus: a cohort study JO - Lancet VL - 353 UR - https://doi.org/10.1016/S0140-6736(98)08468-2 DO - 10.1016/S0140-6736(98)08468-2 ID - Carr1999 ER - TY - JOUR AU - Calza, L. AU - Manfredi, R. AU - Chiodo, F. PY - 2005 DA - 2005// TI - Hyperlactaemia and lactic acidosis in HIV patients receiving antiretroviral therapy JO - Clinical Nutrition VL - 24 UR - https://doi.org/10.1016/j.clnu.2004.03.009 DO - 10.1016/j.clnu.2004.03.009 ID - Calza2005 ER - TY - JOUR AU - Patroni, A. AU - Torti, C. AU - Tomasoni, L. AU - Roldan, E. Q. AU - Bertelli, D. AU - Puoti, M. PY - 2002 DA - 2002// TI - Effect of Highly Active Antiretroviral Therapy (HAART) and hepatitis C co-infection on hyperlipidaemia in HIV infected patients: A retrospective longitudinal study JO - HIV Clin Trials VL - 3 UR - https://doi.org/10.1310/W024-QC4T-NXU0-TKYT DO - 10.1310/W024-QC4T-NXU0-TKYT ID - Patroni2002 ER - TY - JOUR AU - Domingos, H. AU - da Cunha AU - Paniago, A. M. M. AU - Martins, D. M. AU - Elkhoury, E. B. AU - de Souza, A. S. PY - 2009 DA - 2009// TI - Metabolic effects to the Highly Active Antiretroviral Therapy (HAART) in AIDS patients JO - The Brazilian Journal of Infectious Diseases VL - 13 UR - https://doi.org/10.1590/S1413-86702009000200012 DO - 10.1590/S1413-86702009000200012 ID - Domingos2009 ER -